1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Clostridium Difficile Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Narrow Spectrum Antibiotics 1.2.3 Broad Spectrum Antibiotics 1.3 Market by Application 1.3.1 Global Clostridium Difficile Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Clostridium Difficile Treatment Market Perspective (2016-2027) 2.2 Clostridium Difficile Treatment Growth Trends by Regions 2.2.1 Clostridium Difficile Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Clostridium Difficile Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Clostridium Difficile Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Clostridium Difficile Treatment Industry Dynamic 2.3.1 Clostridium Difficile Treatment Market Trends 2.3.2 Clostridium Difficile Treatment Market Drivers 2.3.3 Clostridium Difficile Treatment Market Challenges 2.3.4 Clostridium Difficile Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Clostridium Difficile Treatment Players by Revenue 3.1.1 Global Top Clostridium Difficile Treatment Players by Revenue (2016-2021) 3.1.2 Global Clostridium Difficile Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Clostridium Difficile Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Clostridium Difficile Treatment Revenue 3.4 Global Clostridium Difficile Treatment Market Concentration Ratio 3.4.1 Global Clostridium Difficile Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Clostridium Difficile Treatment Revenue in 2020 3.5 Clostridium Difficile Treatment Key Players Head office and Area Served 3.6 Key Players Clostridium Difficile Treatment Product Solution and Service 3.7 Date of Enter into Clostridium Difficile Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Clostridium Difficile Treatment Breakdown Data by Type 4.1 Global Clostridium Difficile Treatment Historic Market Size by Type (2016-2021) 4.2 Global Clostridium Difficile Treatment Forecasted Market Size by Type (2022-2027) 5 Clostridium Difficile Treatment Breakdown Data by Application 5.1 Global Clostridium Difficile Treatment Historic Market Size by Application (2016-2021) 5.2 Global Clostridium Difficile Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Clostridium Difficile Treatment Market Size (2016-2027) 6.2 North America Clostridium Difficile Treatment Market Size by Type 6.2.1 North America Clostridium Difficile Treatment Market Size by Type (2016-2021) 6.2.2 North America Clostridium Difficile Treatment Market Size by Type (2022-2027) 6.2.3 North America Clostridium Difficile Treatment Market Size by Type (2016-2027) 6.3 North America Clostridium Difficile Treatment Market Size by Application 6.3.1 North America Clostridium Difficile Treatment Market Size by Application (2016-2021) 6.3.2 North America Clostridium Difficile Treatment Market Size by Application (2022-2027) 6.3.3 North America Clostridium Difficile Treatment Market Size by Application (2016-2027) 6.4 North America Clostridium Difficile Treatment Market Size by Country 6.4.1 North America Clostridium Difficile Treatment Market Size by Country (2016-2021) 6.4.2 North America Clostridium Difficile Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Clostridium Difficile Treatment Market Size (2016-2027) 7.2 Europe Clostridium Difficile Treatment Market Size by Type 7.2.1 Europe Clostridium Difficile Treatment Market Size by Type (2016-2021) 7.2.2 Europe Clostridium Difficile Treatment Market Size by Type (2022-2027) 7.2.3 Europe Clostridium Difficile Treatment Market Size by Type (2016-2027) 7.3 Europe Clostridium Difficile Treatment Market Size by Application 7.3.1 Europe Clostridium Difficile Treatment Market Size by Application (2016-2021) 7.3.2 Europe Clostridium Difficile Treatment Market Size by Application (2022-2027) 7.3.3 Europe Clostridium Difficile Treatment Market Size by Application (2016-2027) 7.4 Europe Clostridium Difficile Treatment Market Size by Country 7.4.1 Europe Clostridium Difficile Treatment Market Size by Country (2016-2021) 7.4.2 Europe Clostridium Difficile Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Clostridium Difficile Treatment Market Size (2016-2027) 8.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Type 8.2.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Application 8.3.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Clostridium Difficile Treatment Market Size by Region 8.4.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Clostridium Difficile Treatment Market Size (2016-2027) 9.2 Latin America Clostridium Difficile Treatment Market Size by Type 9.2.1 Latin America Clostridium Difficile Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Clostridium Difficile Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Clostridium Difficile Treatment Market Size by Type (2016-2027) 9.3 Latin America Clostridium Difficile Treatment Market Size by Application 9.3.1 Latin America Clostridium Difficile Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Clostridium Difficile Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Clostridium Difficile Treatment Market Size by Application (2016-2027) 9.4 Latin America Clostridium Difficile Treatment Market Size by Country 9.4.1 Latin America Clostridium Difficile Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Clostridium Difficile Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Clostridium Difficile Treatment Market Size (2016-2027) 10.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Type 10.2.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Application 10.3.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Clostridium Difficile Treatment Market Size by Country 10.4.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Actelion Pharmaceuticals 11.1.1 Actelion Pharmaceuticals Company Details 11.1.2 Actelion Pharmaceuticals Business Overview 11.1.3 Actelion Pharmaceuticals Clostridium Difficile Treatment Introduction 11.1.4 Actelion Pharmaceuticals Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.1.5 Actelion Pharmaceuticals Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Clostridium Difficile Treatment Introduction 11.2.4 Merck Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Clostridium Difficile Treatment Introduction 11.3.4 Pfizer Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Summit Therapeutics 11.4.1 Summit Therapeutics Company Details 11.4.2 Summit Therapeutics Business Overview 11.4.3 Summit Therapeutics Clostridium Difficile Treatment Introduction 11.4.4 Summit Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.4.5 Summit Therapeutics Recent Development 11.5 Astellas Pharma 11.5.1 Astellas Pharma Company Details 11.5.2 Astellas Pharma Business Overview 11.5.3 Astellas Pharma Clostridium Difficile Treatment Introduction 11.5.4 Astellas Pharma Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.5.5 Astellas Pharma Recent Development 11.6 CRESTOVO 11.6.1 CRESTOVO Company Details 11.6.2 CRESTOVO Business Overview 11.6.3 CRESTOVO Clostridium Difficile Treatment Introduction 11.6.4 CRESTOVO Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.6.5 CRESTOVO Recent Development 11.7 Da Volterra 11.7.1 Da Volterra Company Details 11.7.2 Da Volterra Business Overview 11.7.3 Da Volterra Clostridium Difficile Treatment Introduction 11.7.4 Da Volterra Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.7.5 Da Volterra Recent Development 11.8 Immuron 11.8.1 Immuron Company Details 11.8.2 Immuron Business Overview 11.8.3 Immuron Clostridium Difficile Treatment Introduction 11.8.4 Immuron Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.8.5 Immuron Recent Development 11.9 MGB Biopharma 11.9.1 MGB Biopharma Company Details 11.9.2 MGB Biopharma Business Overview 11.9.3 MGB Biopharma Clostridium Difficile Treatment Introduction 11.9.4 MGB Biopharma Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.9.5 MGB Biopharma Recent Development 11.10 Novartis 11.10.1 Novartis Company Details 11.10.2 Novartis Business Overview 11.10.3 Novartis Clostridium Difficile Treatment Introduction 11.10.4 Novartis Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.10.5 Novartis Recent Development 11.11 Otsuka Pharmaceutical 11.11.1 Otsuka Pharmaceutical Company Details 11.11.2 Otsuka Pharmaceutical Business Overview 11.11.3 Otsuka Pharmaceutical Clostridium Difficile Treatment Introduction 11.11.4 Otsuka Pharmaceutical Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.11.5 Otsuka Pharmaceutical Recent Development 11.12 Rebiotix 11.12.1 Rebiotix Company Details 11.12.2 Rebiotix Business Overview 11.12.3 Rebiotix Clostridium Difficile Treatment Introduction 11.12.4 Rebiotix Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.12.5 Rebiotix Recent Development 11.13 Romark Laboratories 11.13.1 Romark Laboratories Company Details 11.13.2 Romark Laboratories Business Overview 11.13.3 Romark Laboratories Clostridium Difficile Treatment Introduction 11.13.4 Romark Laboratories Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.13.5 Romark Laboratories Recent Development 11.14 Sanofi Pasteur 11.14.1 Sanofi Pasteur Company Details 11.14.2 Sanofi Pasteur Business Overview 11.14.3 Sanofi Pasteur Clostridium Difficile Treatment Introduction 11.14.4 Sanofi Pasteur Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.14.5 Sanofi Pasteur Recent Development 11.15 Seres Therapeutics 11.15.1 Seres Therapeutics Company Details 11.15.2 Seres Therapeutics Business Overview 11.15.3 Seres Therapeutics Clostridium Difficile Treatment Introduction 11.15.4 Seres Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.15.5 Seres Therapeutics Recent Development 11.16 Takeda 11.16.1 Takeda Company Details 11.16.2 Takeda Business Overview 11.16.3 Takeda Clostridium Difficile Treatment Introduction 11.16.4 Takeda Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.16.5 Takeda Recent Development 11.17 Synthetic Biologics 11.17.1 Synthetic Biologics Company Details 11.17.2 Synthetic Biologics Business Overview 11.17.3 Synthetic Biologics Clostridium Difficile Treatment Introduction 11.17.4 Synthetic Biologics Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.17.5 Synthetic Biologics Recent Development 11.18 Bausch Health 11.18.1 Bausch Health Company Details 11.18.2 Bausch Health Business Overview 11.18.3 Bausch Health Clostridium Difficile Treatment Introduction 11.18.4 Bausch Health Revenue in Clostridium Difficile Treatment Business (2016-2021) 11.18.5 Bausch Health Recent Development 11.18 Valneva .1 Valneva Company Details .2 Valneva Business Overview .3 Valneva Clostridium Difficile Treatment Introduction .4 Valneva Revenue in Clostridium Difficile Treatment Business (2016-2021) .5 Valneva Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Clostridium Difficile Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Narrow Spectrum Antibiotics Table 3. Key Players of Broad Spectrum Antibiotics Table 4. Global Clostridium Difficile Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Clostridium Difficile Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Clostridium Difficile Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Clostridium Difficile Treatment Market Share by Regions (2016-2021) Table 8. Global Clostridium Difficile Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Clostridium Difficile Treatment Market Share by Regions (2022-2027) Table 10. Clostridium Difficile Treatment Market Trends Table 11. Clostridium Difficile Treatment Market Drivers Table 12. Clostridium Difficile Treatment Market Challenges Table 13. Clostridium Difficile Treatment Market Restraints Table 14. Global Clostridium Difficile Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Clostridium Difficile Treatment Market Share by Players (2016-2021) Table 16. Global Top Clostridium Difficile Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Treatment as of 2020) Table 17. Ranking of Global Top Clostridium Difficile Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Clostridium Difficile Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Clostridium Difficile Treatment Product Solution and Service Table 21. Date of Enter into Clostridium Difficile Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Clostridium Difficile Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Clostridium Difficile Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Clostridium Difficile Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Clostridium Difficile Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Clostridium Difficile Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Clostridium Difficile Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Clostridium Difficile Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Actelion Pharmaceuticals Company Details Table 62. Actelion Pharmaceuticals Business Overview Table 63. Actelion Pharmaceuticals Clostridium Difficile Treatment Product Table 64. Actelion Pharmaceuticals Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 65. Actelion Pharmaceuticals Recent Development Table 66. Merck Company Details Table 67. Merck Business Overview Table 68. Merck Clostridium Difficile Treatment Product Table 69. Merck Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 70. Merck Recent Development Table 71. Pfizer Company Details Table 72. Pfizer Business Overview Table 73. Pfizer Clostridium Difficile Treatment Product Table 74. Pfizer Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 75. Pfizer Recent Development Table 76. Summit Therapeutics Company Details Table 77. Summit Therapeutics Business Overview Table 78. Summit Therapeutics Clostridium Difficile Treatment Product Table 79. Summit Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 80. Summit Therapeutics Recent Development Table 81. Astellas Pharma Company Details Table 82. Astellas Pharma Business Overview Table 83. Astellas Pharma Clostridium Difficile Treatment Product Table 84. Astellas Pharma Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 85. Astellas Pharma Recent Development Table 86. CRESTOVO Company Details Table 87. CRESTOVO Business Overview Table 88. CRESTOVO Clostridium Difficile Treatment Product Table 89. CRESTOVO Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 90. CRESTOVO Recent Development Table 91. Da Volterra Company Details Table 92. Da Volterra Business Overview Table 93. Da Volterra Clostridium Difficile Treatment Product Table 94. Da Volterra Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 95. Da Volterra Recent Development Table 96. Immuron Company Details Table 97. Immuron Business Overview Table 98. Immuron Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 99. Immuron Recent Development Table 100. MGB Biopharma Company Details Table 101. MGB Biopharma Business Overview Table 102. MGB Biopharma Clostridium Difficile Treatment Product Table 103. MGB Biopharma Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 104. MGB Biopharma Recent Development Table 105. Novartis Company Details Table 106. Novartis Business Overview Table 107. Novartis Clostridium Difficile Treatment Product Table 108. Novartis Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 109. Novartis Recent Development Table 110. Otsuka Pharmaceutical Company Details Table 111. Otsuka Pharmaceutical Business Overview Table 112. Otsuka Pharmaceutical Clostridium Difficile Treatment Product Table 113. Otsuka Pharmaceutical Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 114. Otsuka Pharmaceutical Recent Development Table 115. Rebiotix Company Details Table 116. Rebiotix Business Overview Table 117. Rebiotix Clostridium Difficile Treatment Product Table 118. Rebiotix Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 119. Rebiotix Recent Development Table 120. Romark Laboratories Company Details Table 121. Romark Laboratories Business Overview Table 122. Romark Laboratories Clostridium Difficile Treatment Product Table 123. Romark Laboratories Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 124. Romark Laboratories Recent Development Table 125. Sanofi Pasteur Company Details Table 126. Sanofi Pasteur Business Overview Table 127. Sanofi Pasteur Clostridium Difficile Treatment Product Table 128. Sanofi Pasteur Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 129. Sanofi Pasteur Recent Development Table 130. Seres Therapeutics Company Details Table 131. Seres Therapeutics Business Overview Table 132. Seres Therapeutics Clostridium Difficile Treatment Product Table 133. Seres Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 134. Seres Therapeutics Recent Development Table 135. Takeda Company Details Table 136. Takeda Business Overview Table 137. Takeda Clostridium Difficile Treatment Product Table 138. Takeda Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 139. Takeda Recent Development Table 140. Synthetic Biologics Company Details Table 141. Synthetic Biologics Business Overview Table 142. Synthetic Biologics Clostridium Difficile Treatment Product Table 143. Synthetic Biologics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 144. Synthetic Biologics Recent Development Table 145. Bausch Health Company Details Table 146. Bausch Health Business Overview Table 147. Bausch Health Clostridium Difficile Treatment Product Table 148. Bausch Health Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 149. Bausch Health Recent Development Table 150. Valneva Company Details Table 151. Valneva Business Overview Table 152. Valneva Clostridium Difficile Treatment Product Table 153. Valneva Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million) Table 154. Valneva Recent Development Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Global Clostridium Difficile Treatment Market Share by Type: 2020 VS 2027 Figure 2. Narrow Spectrum Antibiotics Features Figure 3. Broad Spectrum Antibiotics Features Figure 4. Global Clostridium Difficile Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Clostridium Difficile Treatment Report Years Considered Figure 9. Global Clostridium Difficile Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Clostridium Difficile Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Clostridium Difficile Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Clostridium Difficile Treatment Market Share by Regions (2022-2027) Figure 13. Global Clostridium Difficile Treatment Market Share by Players in 2020 Figure 14. Global Top Clostridium Difficile Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Clostridium Difficile Treatment Revenue in 2020 Figure 16. Global Clostridium Difficile Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Clostridium Difficile Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Clostridium Difficile Treatment Market Share by Type (2016-2027) Figure 20. North America Clostridium Difficile Treatment Market Share by Application (2016-2027) Figure 21. North America Clostridium Difficile Treatment Market Share by Country (2016-2027) Figure 22. United States Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Clostridium Difficile Treatment Market Share by Type (2016-2027) Figure 26. Europe Clostridium Difficile Treatment Market Share by Application (2016-2027) Figure 27. Europe Clostridium Difficile Treatment Market Share by Country (2016-2027) Figure 28. Germany Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Clostridium Difficile Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Clostridium Difficile Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Clostridium Difficile Treatment Market Share by Region (2016-2027) Figure 38. China Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Clostridium Difficile Treatment Market Share by Type (2016-2027) Figure 46. Latin America Clostridium Difficile Treatment Market Share by Application (2016-2027) Figure 47. Latin America Clostridium Difficile Treatment Market Share by Country (2016-2027) Figure 48. Mexico Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Clostridium Difficile Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Clostridium Difficile Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Clostridium Difficile Treatment Market Share by Country (2016-2027) Figure 54. Turkey Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Actelion Pharmaceuticals Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 58. Merck Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 60. Summit Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 61. Astellas Pharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 62. CRESTOVO Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 63. Da Volterra Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 64. Immuron Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 65. MGB Biopharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 66. Novartis Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 67. Otsuka Pharmaceutical Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 68. Rebiotix Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 69. Romark Laboratories Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 70. Sanofi Pasteur Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 71. Seres Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 72. Takeda Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 73. Synthetic Biologics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 74. Bausch Health Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 75. Valneva Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Actelion Pharmaceuticals Merck Pfizer Summit Therapeutics Astellas Pharma CRESTOVO Da Volterra Immuron MGB Biopharma Novartis Otsuka Pharmaceutical Rebiotix Romark Laboratories Sanofi Pasteur Seres Therapeutics Takeda Synthetic Biologics Bausch Health Valneva